This session will discuss Genzyme's continuous processing plant. The plant has a capacity >500 tons per year. It incorporates Nitech tubular baffled reactor technology instead of traditional high pressure batch reactors. This session will discuss the benefits of the continuous plant including lower costs, speed of construction, low footprint and ease of adding further capacity if required. The plant has been through successful pre-approval inspections with both FDA and MHRA and is currently ramping up to nameplate capacity.